Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China

References

• Huang C, Wang Y, Xingwang L, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• The great lockdown: worst economic downturn since the great depression – IMF Blog. [accessed 2021 May 20]. https://blogs.imf.org/2020/04/14/the-great-lockdown-worst-economic-downturn-since-the-great-depression/.
   Google Scholar
• WHO Coronavirus (COVID-19) dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data. [accessed 2021 March 26]. https://covid19.who.int/.
   Google Scholar
• Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969–73. doi:10.1056/NEJMp2005630.
   PubMed Web of Science ®Google Scholar
• Draft landscape and tracker of COVID-19 candidate vaccines. [accessed 2021 March 29]. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
   Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. LANCET. 2021;397(10278):1023–34. doi:10.1016/S0140-6736(21)00306-8.
   PubMed Web of Science ®Google Scholar
• COVID-19 vaccines. [accessed 2021 March 27]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
   Google Scholar
• COVID-19 vaccination first phase priority groups - GOV.UK. [accessed 2021 May 27]. https://www.gov.uk/government/publications/covid-19-vaccination-care-home-and-healthcare-settings-posters/covid-19-vaccination-first-phase-priority-groups.
   Google Scholar
• ACIP COVID-19 Vaccine Recommendations | CDC. [accessed 2021 May 27]. https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html.
   Google Scholar
• Rosen B, Waitzberg R, Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. ISR J HEALTH POLICY. 2021;10(1). doi:10.1186/s13584-021-00440-6.
   Web of Science ®Google Scholar
• Press Conference of the Joint Prevention and Control Mechanism of the State Council on December. 2020 31 [accessed 2021 March 20]. http://www.gov.cn/xinwen/gwylflkjz143/index.htm.
   Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. NAT MED. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
   PubMed Web of Science ®Google Scholar
• Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–82. doi:10.1007/s10198-020-01208-6.
   PubMed Web of Science ®Google Scholar
• Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, Srouji S, Sela E. Vaccine hesitancy: the next challenge in the fight against COVID-19. EUR J EPIDEMIOL. 2020;35(8):775–79. doi:10.1007/s10654-020-00671-y.
   PubMed Web of Science ®Google Scholar
• Engineering And Medicine National Academies Of Sciences. Vaccine access and hesitancy: part one of a workshop series: proceedings of a workshop—in brief. Washington (DC): The National Academies Press; 2020. p. 5.
   Google Scholar
• Buttenheim AM. SARS-CoV-2 vaccine acceptance: we may need to choose our battles. ANN INTERN MED. 2020;173:1018–19. doi:10.7326/M20-6206.
   Web of Science ®Google Scholar
• Chevallier C, Hacquin AS, Mercier H. COVID-19 vaccine hesitancy: shortening the last mile. TRENDS COGN SCI. 2021;25(5):331–33. doi:10.1016/j.tics.2021.02.
   PubMed Web of Science ®Google Scholar
• Laine C, Cotton D, Moyer DV. COVID-19 vaccine: promoting vaccine acceptance. ANN INTERN MED. 2021;174(2):252–53. doi:10.7326/M20-8008.
   PubMed Web of Science ®Google Scholar
• Dubé E, and MacDonald NE. Chapter 26 - vaccine acceptance: barriers, perceived risks, benefits, and irrational beliefs. In: Bloom BR, and Lambert P-H, editors. The vaccine book. 2nd ed. Cambridge, MA, USA: Academic Press;2016. p.507–528.
   Google Scholar
• Report of the Sage Working Group on Vaccine Hesitancy. [accessed 2021 March 2]. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf.
   Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–59. doi:10.1016/j.vaccine.2014.01.081.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. LANCET. 2011;378(9790):526–35. doi:10.1016/S0140-6736(11)60678-8.
   PubMed Web of Science ®Google Scholar
• Kelly BJ, Southwell BG, McCormack LA, Bann CM, MacDonald PDM, Frasier AM, Bevc CA, Brewer NT, Squiers LB. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis. 2021;21(1). doi:10.1186/s12879-021-06023-9
   Web of Science ®Google Scholar
• Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Network Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.255942020-10-20.
   PubMed Web of Science ®Google Scholar
• Nguyen KH, Srivastav A, Razzaghi H, Williams W, Lindley MC, Jorgensen C, Abad N, Singleton JA. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination - United States, September and December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(6):217–22. doi:10.15585/mmwr.mm7006e3.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–21. doi:10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Lin C, Pikuei T, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2021;9(1):16. doi:10.3390/vaccines90100162020-12-30.
   Web of Science ®Google Scholar
• Robinson E, Jones A, Lesser I, Michael D. International estimates of intended uptake and refusal of COVID-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples. VACCINE. 2021;39(15):2024–34. doi:10.1016/j.vaccine.2021.02.005.
   PubMed Web of Science ®Google Scholar
• Graffigna G, Palamenghi L, Boccia S, Barello S. Relationship between citizens’ health engagement and intention to take the COVID-19 vaccine in Italy: a mediation analysis. Vaccines. 2020;8(4):576. doi:10.3390/vaccines80405762020-10-01.
   Web of Science ®Google Scholar
• Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother. 2021;17(6):1622–27. doi:10.1080/21645515.2020.1847585.
   PubMed Web of Science ®Google Scholar
• Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8(3):482. doi:10.3390/vaccines80304822020-08-27.
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M. Acceptance of a COVID-19 vaccine in southeast asia: a cross-sectional study in Indonesia. Front Public Health. 2020:8. doi:10.3389/fpubh.2020.003812020-07-14.
   Web of Science ®Google Scholar
• Yoda T, Katsuyama H. Willingness to Receive COVID-19 Vaccination in Japan. Vaccines. 2021;9(1):48. doi:10.3390/vaccines90100482021-01-14.
   PubMed Web of Science ®Google Scholar
• Chen S, Yang J, Yang W, Wang C, Barnighausen T. COVID-19 control in China during mass population movements at New Year. Lancet. 2020;395(10226):764–66. doi:10.1016/S0140-6736(20)30421-9.
   PubMed Web of Science ®Google Scholar
• Burki T. China’s successful control of COVID-19. Lancet Infect Dis. 2020;20(11):1240–41. doi:10.1016/S1473-3099(20)30800-8.
   PubMed Web of Science ®Google Scholar
• Wang J, Xinran L, Lai X, Lyu Y, Zhang H, Fenghuang Y, Jing R, Li L, Yu W, Fang H, et al. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: Longitudinal study A. Vaccines. 2021;9(3):191. doi:10.3390/vaccines9030191.
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhijian H, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLOS NEGLECT TROP D. 2020;14(12):e8961. doi:10.1371/journal.pntd.00089612020-12-17.
   PubMed Web of Science ®Google Scholar
• Press Conference of the Joint Prevention and Control Mechanism of the State Council on January. 2021 13 [accessed 2021 March 20]. http://www.gov.cn/xinwen/gwylflkjz145/index.htm.
   Google Scholar
• Baumgaertner B, Ridenhour BJ, Justwan F, Carlisle JE, Miller CR. Risk of disease and willingness to vaccinate in the United States: a population-based survey. PLoS Med. 2020;17(10):e1003354. doi:10.1371/journal.pmed.1003354.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Wyka K, Rauh L, Rabin K, Ratzan S, Gostin LO, Larson HJ, El-Mohandes A. Hesitant or not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. J Health Commun. 2020;25(10):799–807. doi:10.1080/10810730.2020.1868630.
   PubMed Web of Science ®Google Scholar
• Verger P, Eve D. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020;19(11):991–93. doi:10.1080/14760584.2020.1825945.
   PubMed Web of Science ®Google Scholar
• Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–93. doi:10.1080/21645515.2020.1780846.
   PubMed Web of Science ®Google Scholar
• Schiavo R. Vaccine communication in the age of COVID-19: getting ready for an information war. J Commun Healthc. 2020;13(2):73–75. doi:10.1080/17538068.2020.1778959.
   Google Scholar
• Coronavirus (COVID-19) vaccinations - statistics and research - our world in data. [accessed 2021 March 27]. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL.
   Google Scholar
• Wu S, Yang P, Li H, Ma C, Zhang Y, Wang Q. Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study. BMC Public Health. 2013;13:636. doi:10.1186/1471-2458-13-636.
   PubMed Web of Science ®Google Scholar
• Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine. 2012;30(7):1255–64. doi:10.1016/j.vaccine.2011.12.089.
   PubMed Web of Science ®Google Scholar
• Chen M, Li Y, Chen J, Wen Z, Feng F, Zou H, Fu C, Chen L, Shu Y, Sun, C. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother. 2021;1–10. doi:10.1080/21645515.2020.1853449.
   Web of Science ®Google Scholar
• Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. COVID-19 vaccination willingness among Chinese adults under the free vaccination policy. Vaccines. 2021;9(3):292. doi:10.3390/vaccines9030292.
   PubMed Web of Science ®Google Scholar
• Tsai F, Yang H, Lin C, Liu JZ. Acceptability of COVID-19 vaccines and protective behavior among adults in Taiwan: associations between risk perception and willingness to vaccinate against COVID-19. INT J ENV RES PUB HE. 2021;18(11):5579. doi:10.3390/ijerph18115579.
   PubMed Web of Science ®Google Scholar
• Murphy J, Vallieres F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. NAT COMMUN. 2021;12(1):29. doi:10.1038/s41467-020-20226-9.
   PubMed Web of Science ®Google Scholar
• Sethi S, Kumar A, Mandal A, Shaikh M, Hall CA, Kirk JMW, Moss P, Brookes MJ, Basu S. The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy. BMJ OPEN. 2021;11(6):e48856.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. VACCINE. 2021;39(7):1148–56. doi:10.1016/j.vaccine.2020.12.083.
   PubMed Web of Science ®Google Scholar
• Alabdulla M, Reagu SM, Al Khal A, Elzain M, Jones RM. COVID‐19 vaccine hesitancy and attitudes in Qatar: a national cross‐sectional survey of a migrant‐majority population. Influenza Other Resp. 2021;15(3):361–70. doi:10.1111/irv.12847.
   PubMed Web of Science ®Google Scholar
• Gan L, Chen Y, Hu P, Wu D, Zhu Y, Tan J, Li Y, Zhang D. Willingness to receive SARS-CoV-2 vaccination and associated factors among Chinese adults: a cross sectional survey. Int J Environ Res Public Health. 2021;18(4). doi:10.3390/ijerph18041993.
   Web of Science ®Google Scholar
• Rui M, Suo L, Lu L, Pang X. Willingness of the general public to receive the COVID-19 vaccine during a second-level alert — Beijing municipality, China, May 2020. China CDC Weekly. 2021;3(25):531–37. doi:10.46234/ccdcw2021.118.
   PubMedGoogle Scholar
• These Countries Did Well With Covid. So Why Are They Slow on Vaccines? The New York Times. [accessed 2021 May 27]. https://www.nytimes.com/2021/04/17/world/asia/Japan-south-Korea-Australia-vaccines.html.
   Google Scholar
• Press Conference of the Joint Prevention and Control Mechanism of the State Council on March. 2020 28 [accessed 2021 Sept 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.
   Google Scholar
• Question and Answer for COVID-19 Vaccination. [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/2021-04/01/content_5597357.htm.
   Google Scholar
• Mohamadi M, Lin Y, Vulliet MVS, Flahault A, Rozanova L, Fabre G. COVID-19 vaccination strategy in China: a case study. Epidemiologia. 2021;2(3):402–25. doi:10.3390/epidemiologia2030030.
   PubMedGoogle Scholar
• Press Conference of the Joint Prevention and Control Mechanism of the State Council on September. 2020 18 [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.
   Google Scholar
• The 76th Press Conference on COVID-19 Prevention and Control in Zhejiang Province. [accessed 2021 Spet 21]. https://baijiahao.baidu.com/s?id=1708413801540021226&wfr=spider&for=pc.
   Google Scholar
• In Guangdong, 90% of people aged 12 and above were vaccinated against COVID-19. [accessed 2021 Spet 21]. https://m.gmw.cn/baijia/2021-09/08/1302561119.html.
   Google Scholar
• Press Conference of the Joint Prevention and Control Mechanism of the State Council on September. 2020 6 [accessed 2021 Spet 21]. http://www.gov.cn/xinwen/gwylflkjz153/index.htm.
   Google Scholar